Searchable abstracts of presentations at key conferences in oncology

oa0001p032 | (1) | PacRim7

Clinical validation of circulating cytokines as markers of prognosis and response to docetaxel in men with metastatic castration resistant prostate cancer

Mahon KL , Lin HM , Lee-Ng M , Cain D , Jacobs C , Stockler MR , Gurney H , Mallesara G , Briscoe K , Marx G , Higano C , de Bono JS , Chi KN , Breit SN , Brown DA , Horvath LG

Background: Elevated circulating macrophage inhibitory cytokine -1/growth differentiation factor 15 (MIC-1/GDF15), interleukins 4 (IL4) and 6 (IL6) levels were associated with poor prognosis and resistance to docetaxel chemotherapy in an exploratory cohort of men with metastatic castration resistant prostate cancer (mCRPC). To establish level 2 evidence of biomarker utility, these cytokines were tested in internal and external validation cohorts.Methods:...

oa0001p051 | (1) | PacRim7

Targeting HP1-alpha for prevention and treatment of neuroendocrine prostate cancer

Ci Xinpei , Lin Dong , Collins Colin , Lallous Nada , Hsing Michael , Cherkasov Art , Wang Yuzhuo

NEPC is a lethal subtype of PCa frequently arising from adenocarcinoma via NE transdifferentiation following ADT. In AACR-PCF West Dream Team series of sequential biopsies of over 300 CRPC biopsies, NEPC was discovered in 17% of cases, making neuroendocrine transdifferentiation one of the most common mechanisms underlying ADT resistance. However, a mechanistic understanding of both NEPC development and its aggressiveness remain elusive. Research in this field has been hampered...

oa0001p038 | (1) | PacRim7

Flicking the switch off, targeting MCL-1 in the treatment of breast and prostate cancer

Castillo L , George S , Lin H-M , Yeung N , Mawson A , Young AI , Law AM , Hastings J , Gallego-Ortega D , Deng N , Croucher D , Swarbrick A , Horvath L , Ormandy CJ , Oakes SR

The ability to survive is essential for carcinogenesis. We previously showed that in to addition promoting cancer cell survival, Myeloid Cell Leukemia 1 (MCL-1) regulates cancer cell invasion possibly via direct regulation of the cytoskeletal protein Cofilin and via modulation of the output of the SRC family kinase pathway. We also showed that dual inhibition of MCL-1 and SRC family kinases was effective in suppressing metastasis of breast cancer intraductal xenografts made fr...